This combination powder is a triple-action respiratory therapy formulated for patients with chronic obstructive pulmonary disease (COPD) and asthma requiring maintenance treatment. It contains: Vilanterol 25 mcg – a long-acting β2-agonist (LABA) that helps relax airway muscles, improving airflow and reducing bronchospasm. Fluticasone 100 mcg – an inhaled corticosteroid (ICS) that reduces airway inflammation and prevents exacerbations. Umeclidinium Bromide 62.5 mcg – a long-acting muscarinic antagonist (LAMA) that blocks airway constriction and improves lung function. This combination provides effective bronchodilation, anti-inflammatory action, and sustained symptom control, making it ideal for patients requiring dual or triple maintenance therapy for moderate to severe COPD or asthma. The powder formulation ensures rapid delivery to the lungs and convenient inhalation.
